Clinical outcomes of circumferential endoscopic submucosal dissection in esophageal squamous cell carcinoma > 50 mm: Retrospective cohort study
Endoscopy International Open · 19.12.2025 · 13 (CP)
DOI: 10.1055/a-2760-6112 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Endoscopy International Open, erschienen am 19.12.2025. Verfasst von Takakazu Miyake und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapporo Medical University.
Abstract (Originalsprache)
This study aimed to assess both short-term safety and long-term outcomes of whole circumferential endoscopic submucosal dissection (WC-ESD) for esophageal squamous cell carcinoma (ESCC) with tumor length > 50 mm, and to evaluate effectiveness of aggressive prophylactic dilation combined with steroid therapy in preventing esophageal stricture. A retrospective review was conducted on 67 patients who underwent WC-ESD for superficial ESCC between 2009 and 2019 at a single Japanese center. Patients were categorized into > 50-mm and ≤ 50-mm groups. The primary endpoint was incidence of post-ESD stricture in the main analysis excluding surgery/chemoradiotherapy cases within 90 days; sensitivity analysis included all patients. Secondary endpoints were number of dilations, steroid use, and long-term survival outcomes (overall survival [OS], disease-specific survival [DSS], relapse-free survival [RFS]). Stricture incidence was not significantly different (> 50 mm vs. ≤ 50 mm: 13% vs. 18%, P = 0.708; sensitivity: 21% vs. 15%, P = 0.538). Although dilations were more frequent in the > 50-mm group (96% vs. 83%), median sessions were similar (8 vs. 7.5). Prophylactic dilation plus steroids reduced refractory strictures (25%→7%, P = 0.03). For pT1a-EP/LPM cases, 5-year OS, DSS, and RFS were 100% in both groups. In pT1a-MM/pT1b cases, survival was comparable, although OS tended to be lower with > 50-mm lesions (68.9% vs. 100%, P = 0.07). WC-ESD for superficial ESCC with a tumor length > 50 mm did not increase adverse events and provided comparable long-term survival. These findings support feasibility beyond guideline limits and emphasize further refinement of stricture prevention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.
- Department of Gastroenterology, Keiyukai Daini Hospital, Sapporo, Japan.
ORCID-Profile: Takakazu Miyake
Förderung
- Sapporo Medical University
Zitieren
APA
Miyake, T., Takahashi, H., Okahara, S., Takizawa, A., Yokoyama, T., Kodaira, J., Ishigami, K., Yoshii, S., & Nakase, H. (2025). Clinical outcomes of circumferential endoscopic submucosal dissection in esophageal squamous cell carcinoma > 50 mm: Retrospective cohort study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2760-6112
Vancouver
Miyake T, Takahashi H, Okahara S, Takizawa A, Yokoyama T, Kodaira J, et al. Clinical outcomes of circumferential endoscopic submucosal dissection in esophageal squamous cell carcinoma > 50 mm: Retrospective cohort study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2760-6112
BibTeX
@article{Miyake2025,
author = {Miyake, Takakazu and Takahashi, Hiroaki and Okahara, Satoshi and Takizawa, Ayumu and Yokoyama, Takashi and Kodaira, Junichi and Ishigami, Keisuke and Yoshii, Shinji and Nakase, Hiroshi},
title = {Clinical outcomes of circumferential endoscopic submucosal dissection in esophageal squamous cell carcinoma > 50 mm: Retrospective cohort study},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2760-6112}
}
EUVIMED